Culture Biosciences is revolutionizing bioprocess development with cloud-connected bioreactors and software that streamline the design, monitoring, and analysis of cell culture experiments. Their innovative platform, Console TM, allows scientists to conduct experiments remotely, providing real-time data access and analytics tools that enhance flexibility and scalability. By offering modular bioreactors and a service model that integrates seamlessly into existing lab infrastructures, Culture Biosciences accelerates the development of protein therapeutics, viral vectors, and synthetic biology applications, positioning itself as a leader in the biomanufacturing space.

Lavoro Agro is a a distributor of agricultural inputs.

To support a growing population efficiently, we need to shrink the land, water, and energy footprint of our crops. Breeding is directed evolution, but it is slow and inefficient. Ohalo's technology shrinks the breeding cycles of plants. Our speed, accuracy, and scalability create entirely new varieties of the world's most loved and consumed crops.

Pattern AG uses predictive analytics to help farmers with input decisions such as crop protection, seed selection, and fertility needs. Pattern envisions a future where conventional agricultural inputs are enhanced and eventually replaced by precision microbiome engineering, improving farm productivity and sustainability.

Stenon’s sensor technology enables agronomists to achieve soil nutrient optimization for their growers to save up to 20% of input costs while stabilizing or increasing yields.

At Supergut, we are pioneering breakthrough clinically validated solutions that transform your life through your gut microbiome. For those who want proven real-food products that deliver measurable health results, we provide science-based and delicious products — shakes, snack bars, and more — that balance the microbiome to improve quality of life. Supergut is backed by leading venture investors and visionaries in health, science, and technology, including The Production Board, Alpha Edison, and Acre Venture Partners.

The EVERY Company is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animal agriculture with a more sustainable, kinder, and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them.

Founded by Dave Friedberg, The Production Board (TPB) is a holding company established to solve the most fundamental problems that affect our planet by reimagining global systems of production across food, agriculture, biomanufacturing, human health, and the broader life sciences. TPB builds new businesses from scratch based on emerging scientific discoveries, partners with exceptional talent, and provides them with the capital, infrastructure, and market insights needed to deliver at least a 10x improvement in the cost, energy, time, or carbon footprint of conventional systems. Learn more about our efforts at www.tpb.co.

Tillable is the first true online marketplace for the $32 billion U.S. farmland rental market, optimizing returns for landowners and helping farmers access land to expand operations. For more information, call 833.845.5225 or visit www.tillable.com.

Triplebar is a biotechnology company focused on harnessing evolutionary intelligence to accelerate biological research and product development. By leveraging advanced AI and innovative methodologies, Triplebar aims to create sustainable solutions in food and nutrition, as well as biologics, addressing critical global challenges such as food scarcity and healthcare needs. Their platform delivers datasets more efficiently, enabling faster and more relevant research outcomes. With a commitment to revolutionizing the biotechnology landscape, Triplebar positions itself as a leader in the industry, catering to a growing demand for innovative biotechnological solutions.

We discover the 1 in a million 10,000x faster. Harnessing evolution means giving nature the time and space to find complex solutions. Current technology falls short of the scale required to accelerate this process. The current state of the art is to rely on technology like liquid-handling robotics to look for a 1-in-a-million solution using a method that can only search through thousands of samples. At Triplebar, we measure the effect of billions of mutations. We oversample the genome every day and use this capacity to quickly find solutions to the greatest problems we face.